Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) is now available.
JOINN Laboratories (China) Co., Ltd. has announced a proposed final cash dividend of RMB 0.12 per share for the financial year ended 31 December 2025, with payment to eligible shareholders expected by no later than 31 August 2026. The dividend will be paid in Hong Kong dollars at an exchange rate to be announced, and key dates such as the ex-dividend date, record date and shareholder approval timetable will be confirmed later.
The company will withhold 10% PRC enterprise income tax on dividends distributed to non-resident enterprise shareholders whose names appear on the H share register, including those held through nominees such as HKSCC Nominees Limited. Overseas individual shareholders on the H share register will not be subject to PRC individual income tax withholding on this dividend, clarifying the post-tax payout structure and providing transparency on the treatment of different investor categories.
The most recent analyst rating on (HK:6127) stock is a Hold with a HK$28.00 price target. To see the full list of analyst forecasts on JOINN Laboratories (China) Co., Ltd. Class H stock, see the HK:6127 Stock Forecast page.
More about JOINN Laboratories (China) Co., Ltd. Class H
JOINN Laboratories (China) Co., Ltd. is a Hong Kong-listed company whose H shares trade under stock code 06127. The group operates in the life sciences and pharmaceutical services space, providing research and development-related laboratory services to biopharma and healthcare clients in China and international markets.
Average Trading Volume: 3,815,454
Technical Sentiment Signal: Hold
Current Market Cap: HK$23.84B
For an in-depth examination of 6127 stock, go to TipRanks’ Overview page.